Genetic Toxicology Testing
BioReliance offers genetic toxicology services for the detection of toxic, mutagenic, clastogenic and morphological transforming activity in a number of well-characterized test systems. Our scientific staff and state-of-the-art facilities provide the most current and comprehensive genetic toxicology resources available anywhere.
Comprehensive End to End Solutions for Genotoxicity Assessment
Genotoxicity assessment has long been an important and required aspect of product development. As the worldwide leader in Genetic Toxicology, BioReliance is uniquely positioned to provide the assays, testing paradigms and expert advice to assist in the safety and hazard assessment of your products in development.
BioReliance offers individual toxicology assays or can tailor a comprehensive testing program for your specific needs. Study protocols are designed according to international guidelines (FDA, EPA, OECD, EU, JMHW, and JMAFF) and are conducted in full compliance with Good Laboratory Practice (GLP) standards. We apply the most current battery of tests available for the detection of genotoxic potential.
Gene Tox assays support interpretation of other toxicology results, provide support for regulatory decisions, alert producers and users of potential hazard and help with drug discovery decisions.
- Screening Assays
- Regulatory Submission Assays
- Tier II (Follow-Up Mechanistic Assays)
- REACH Testing Services
Click here: Genetic Toxicology Programs for Early Discovery and Lead Assessment
Click here to contact us for additional assay and services information for Genetic Toxicology.
Copyright © 2017 Sigma-Aldrich Co. LLC. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany Terms | Privacy